We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Derriston Cap. | LSE:DERR | London | Ordinary Share | GB00BYYMVL73 | ORD 2.5P |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 15.65 | 15.50 | 15.80 | 0.00 | 01:00:00 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| 0 | 0 | N/A | 0 |
From Apr 2019 to Apr 2024
TIDMDERR
RNS Number : 6302A
Derriston Capital PLC
27 March 2017
Derriston Capital plc
Director Declaration
Derriston Capital plc, which has been created to consider opportunities within the global medical technology industry, announces that Harry Hyman, non-executive Chairman, is a non-executive Director of BioPharma Credit plc, which began trading on the London Stock Exchange this morning.
For information please contact:
Walbrook PR Ltd Tel: 020 7933 8780 Paul McManus lifesciences@walbrookpr.com
This information is provided by RNS
The company news service from the London Stock Exchange
END
RDNMMGZFMNVGNZM
(END) Dow Jones Newswires
March 27, 2017 07:18 ET (11:18 GMT)
1 Year Derriston Cap. Chart |
1 Month Derriston Cap. Chart |
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
